Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Inviragen Merges With SingVax
Inviragen and SingVax have merged their complementary vaccine pipelines and their international product development capabilities to create a company that would develop vaccines for infectious diseases prevalent in
Inviragen and SingVax have merged their complementary vaccine pipelines and their international product development capabilities to create a company that would develop vaccines for infectious diseases prevalent in
Lupin has granted Salix Pharmaceuticals the exclusive US rights for its bioadhesive drug delivery technology for use with Rifaximin. Lupin and Salix have entered into an agreement under
Coldpack has revealed that it is going to preview its latest environmentally friendly pharmaceutical Pouch at the Pack Expo. The company said that the pouch is equipped with
Enzon Pharmaceuticals has reported that the FDA Oncologic Drug Advisory Committee has voted in favor of approval of Pegintron as a treatment in addition to surgery in patients
Depomed has reported top-line results from a phase 3 clinical trial of DM-1796, also referred to as gabapentin ER. It showed to achieve a significant reduction in pain
Cellix has entered into a distribution agreement with Germany-based Chromaphor Analysen-Tecknik, to handle sales and service agreements for Cellix products in Germany. Vivienne Williams, chief executive officer of
Advanced Liquid Logic co-founder and the HIV study’s Principal Investigator Michael Pollack said, “Our substantial developmental progress and the promise of a sample-to-answer solution in molecular diagnostics made
Abacus Parenterals Drugs has opened a drug factory in Uganda with an aim to serve the targeted market. Ramesh Babu, managing director of Abacus Parenterals Drugs, said: “The
Anavex Life Sciences has selected Forenap Pharma as the contract research organization (CRO) for phase I clinical trials of Anavex 2-73, the company’s lead Alzheimer’s drug candidate. Herve
Baxter has announced that the Committee for Medicinal Products for Human Use (CHMP) of the EMEA granted its ‘positive opinion’ for CELVAPAN H1N1 pandemic vaccine using Baxter’s Vero